Literature DB >> 18362376

Diagnosis and treatment of dementia: 2. Diagnosis.

Howard H Feldman1, Claudia Jacova, Alain Robillard, Angeles Garcia, Tiffany Chow, Michael Borrie, Hyman M Schipper, Mervin Blair, Andrew Kertesz, Howard Chertkow.   

Abstract

BACKGROUND: Dementia can now be accurately diagnosed through clinical evaluation, cognitive screening, basic laboratory evaluation and structural imaging. A large number of ancillary techniques are also available to aid in diagnosis, but their role in the armamentarium of family physicians remains controversial. In this article, we provide physicians with practical guidance on the diagnosis of dementia based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, held in March 2006.
METHODS: We developed evidence-based guidelines using systematic literature searches, with specific criteria for study selection and quality assessment, and a clear and transparent decision-making process. We selected studies published from January 1996 to December 2005 that pertained to key diagnostic issues in dementia. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care.
RESULTS: Of the 1591 articles we identified on all aspects of dementia diagnosis, 1095 met our inclusion criteria; 620 were deemed to be of good or fair quality. From a synthesis of the evidence in these studies, we made 32 recommendations related to the diagnosis of dementia. There are clinical criteria for diagnosing most forms of dementia. A standard diagnostic evaluation can be performed by family physicians over multiple visits. It involves a clinical history (from patient and caregiver), a physical examination and brief cognitive testing. A list of core laboratory tests is recommended. Structural imaging with computed tomography or magnetic resonance imaging is recommended in selected cases to rule out treatable causes of dementia or to rule in cerebrovascular disease. There is insufficient evidence to recommend routine functional imaging, measurement of biomarkers or neuropsychologic testing.
INTERPRETATION: The diagnosis of dementia remains clinically integrative based on history, physical examination and brief cognitive testing. A number of core laboratory tests are also recommended. Structural neuroimaging is advised in selected cases. Other diagnostic approaches, including functional neuroimaging, neuropsychological testing and measurement of biomarkers, have shown promise but are not yet recommended for routine use by family physicians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362376      PMCID: PMC2267847          DOI: 10.1503/cmaj.070798

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  60 in total

Review 1.  Depression, dementia, and pseudodementia.

Authors:  Dorcas J Dobie
Journal:  Semin Clin Neuropsychiatry       Date:  2002-07

2.  The behavioural neurology assessment.

Authors:  S Darvesh; L Leach; S E Black; E Kaplan; M Freedman
Journal:  Can J Neurol Sci       Date:  2005-05       Impact factor: 2.104

3.  Can you have dementia with an MMSE score of 30?

Authors:  Jonah S Shiroky; Hyman M Schipper; Howard Bergman; Howard Chertkow
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Oct-Nov       Impact factor: 2.035

4.  Clinical diagnosis of dementia.

Authors:  Alain Robillard
Journal:  Alzheimers Dement       Date:  2007-10       Impact factor: 21.566

5.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Authors:  Trey Sunderland; Gary Linker; Nadeem Mirza; Karen T Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

6.  Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia.

Authors:  C G Ballard; G Ayre; J O'Brien; A Sahgal; I G McKeith; P G Ince; R H Perry
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Mar-Apr       Impact factor: 2.959

7.  Structural neuroimaging in the diagnosis of dementia.

Authors:  Tiffany Chow
Journal:  Alzheimers Dement       Date:  2007-09-10       Impact factor: 21.566

8.  Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia.

Authors:  Andrew Kertesz; Wilda Davidson; Patricia McCabe; David Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Oct-Dec       Impact factor: 2.703

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

10.  Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Authors:  Piotr Lewczuk; Hermann Esselmann; Mirko Bibl; Georg Beck; Juan Manuel Maler; Markus Otto; Johannes Kornhuber; Jens Wiltfang
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

View more
  60 in total

1.  Behaviour management in dementia.

Authors:  Peter Kapusta; Loren Regier; Julia Bareham; Brent Jensen
Journal:  Can Fam Physician       Date:  2011-12       Impact factor: 3.275

2.  The rural older adult memory (ROAM) study: a practice-based intervention to improve dementia screening and diagnosis.

Authors:  Linda Boise; Elizabeth Eckstrom; Lyle Fagnan; Anne King; Monica Goubaud; David I Buckley; Cynthia Morris
Journal:  J Am Board Fam Med       Date:  2010 Jul-Aug       Impact factor: 2.657

3.  Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study.

Authors:  Wayne Katon; Henrik Sondergaard Pedersen; Anette Riisgaard Ribe; Morten Fenger-Grøn; Dimitry Davydow; Frans Boch Waldorff; Mogens Vestergaard
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

Review 4.  How applicable are clinical practice guidelines to elderly patients with comorbidities?

Authors:  Donatus R Mutasingwa; Hong Ge; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

Review 5.  Building capacity for dementia care: training program to develop primary care memory clinics.

Authors:  Linda Lee; M Janet Kasperski; W Wayne Weston
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

6.  Reducing pill burden and helping with medication awareness to improve adherence.

Authors:  Barbara Farrell; Véronique French Merkley; Nafisa Ingar
Journal:  Can Pharm J (Ott)       Date:  2013-09

7.  Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia.

Authors:  Denys T Lau; Nathaniel D Mercaldo; Andrew T Harris; Emily Trittschuh; Joseph Shega; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

8.  Improving the quality of life in patients with Alzheimer's disease.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2008-08

9.  Progressive impairment of cognition and motor function: Hashimoto encephalopathy.

Authors:  Peter Tzakas; Sze Wan Sit
Journal:  CMAJ       Date:  2011-02-14       Impact factor: 8.262

Review 10.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.